Australia markets closed

Armata Pharmaceuticals, Inc. (TG1N.F)

Frankfurt - Frankfurt Delayed price. Currency in EUR
Add to watchlist
2.3800+0.0200 (+0.85%)
As of 08:34AM CEST. Market open.
Currency in EUR
Earnings estimateCurrent qtr. (Sep 2021)Next qtr. (Dec 2021)Current year (2021)Next year (2022)
No. of analysts3333
Avg. Estimate-0.26-0.26-1.04-0.92
Low estimate-0.27-0.3-1.08-1.23
High estimate-0.25-0.22-1.01-0.73
Year ago EPS-0.31-0.36-1.35-1.04
Revenue estimateCurrent qtr. (Sep 2021)Next qtr. (Dec 2021)Current year (2021)Next year (2022)
No. of analysts3333
Avg. Estimate1.08M1.11M4.41M3.21M
Low estimate800k800k3.8MN/A
High estimate1.23M1.29M4.75M5.34M
Year ago salesN/A504k823k4.41M
Sales growth (year/est)N/A120.20%435.80%-27.20%
Earnings history30/09/202031/12/202031/03/202130/06/2021
Est. EPS-0.24-0.29-0.32-0.26
Actual EPS-0.31-0.36-0.27-0.25
Difference-0.07-0.070.050.01
Surprise %-29.20%-24.10%15.60%3.80%
EPS trendCurrent qtr. (Sep 2021)Next qtr. (Dec 2021)Current year (2021)Next year (2022)
Current estimate-0.26-0.26-1.04-0.92
7 days ago-0.26-0.26-1.04-0.92
30 days ago-0.26-0.26-1.04-0.92
60 days ago-0.24-0.23-1.01-1.08
90 days ago-0.24-0.23-1.01-1.08
EPS revisionsCurrent qtr. (Sep 2021)Next qtr. (Dec 2021)Current year (2021)Next year (2022)
Up last 7 daysN/AN/AN/AN/A
Up last 30 daysN/AN/AN/AN/A
Down last 7 daysN/AN/AN/AN/A
Down last 30 daysN/AN/AN/AN/A
Growth estimatesTG1N.FIndustrySector(s)S&P 500
Current qtr.16.10%N/AN/AN/A
Next qtr.27.80%N/AN/AN/A
Current year23.00%N/AN/AN/A
Next year11.50%N/AN/AN/A
Next 5 years (per annum)N/AN/AN/AN/A
Past 5 years (per annum)N/AN/AN/AN/A